Open an account

InspireMD

NSPR · NASDAQ

$0.4385−$0.0015 (−0.34%)TodayMarket closed ·
Prev close $0.44

About NSPR

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The company is headquartered in Miami, Florida and currently employs 127 full-time employees. The company went IPO on 2013-04-12. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Employees
127
Headquarters
Miami, Florida
Listed
Apr 12, 2013
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
inspiremd.com

NSPR key statistics

Market cap
20.39M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
128.47K
Volume
70.64K
Open price
$0.4537
High today
$0.4785
Low today
$0.434
52 Week high
$2.41
52 Week low
$0.4366

InspireMD (NSPR) at a glance

InspireMD (NSPR) last traded at $0.4385, with a market cap of 20.39M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.434 and $0.4785. The current price is 1.0% above the day's low and 8.4% below its high.

Volume so far is 70.64K shares, below the average of 128.47K shares a day.

Over the past year InspireMD has ranged from $0.4366 to $2.41, and now sits 0% of the way up that range.

InspireMD met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported -$0.17 per share against an estimate of -$0.204.

The average analyst price target is $3.40, 675.4% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $3.40
Low
$3.03
Now
$0.4385
High
$4.20

NSPR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 14.4% on average.

  1. Q3 FY24: reported -$0.16 per share against an estimate of -$0.204
  2. Q4 FY24: reported -$0.19 per share against an estimate of -$0.1989
  3. Q1 FY25: reported -$0.22 per share against an estimate of -$0.204
  4. Q2 FY25: reported -$0.26 per share against an estimate of -$0.2652
  5. Q3 FY25: reported -$0.17 per share against an estimate of -$0.1989
  6. Q4 FY25: reported -$0.14 per share against an estimate of -$0.1972
  7. Q1 FY26: reported -$0.16 per share against an estimate of -$0.1836
  8. Q2 FY26: reported -$0.17 per share against an estimate of -$0.204

NSPR news

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseBusiness Wire

    Biobeat Technologies Names Raymond W. Cohen as Chairman of the Board of Directors

  • Earnings Scheduled For August 5, 2025

  • A Look Ahead: InspireMD's Earnings Forecast

  • Press releaseGlobe Newswire

    InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

  • Press releaseGlobe Newswire

    InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

Similar companies

Companies in the same industry as InspireMD

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.